When natural or live enzymes are utilised to initiate or speed up a chemical reaction, this process is referred to as enzyme biocatalysis. In 1858, Louis Pasteur conducted one of the earliest instances of contemporary enzyme biocatalysis. In order to create tartaric acid, Pasteur utilised a variety of microorganisms, including the mould Penicillium glaucum, as enzymes in a fermentation process. There are several applications for tartaric acid, including cleaning different metals, tanning leather, and food preservation. One of the first recorded cases of enzyme biocatalysis was carried out by renowned scientist Louis Pasteur. Metals have been used as catalysts in several sectors for many years. They may be made at a low cost and decompose naturally. They frequently perform quicker reactions at lower concentrations, which is one advantage of these enzymes employed in biocatalysis.
Frequently, they can operate in aqueous conditions and at less abrasive pH and temperature ranges.
They can be made in considerably greater quantities.
For a certain reaction, they may be made to be much more targeted.
Various plants (such as carrots and soy), fungi (such as mushrooms), bacteria, and animal organs like pigs' livers are just a few of the sources of these enzymes. Using recombinant DNA technology, newer versions of these enzymes can be created.
Stanislaw Dzwigaj
Sorbonne University, France
Thomas J Webster
Brown University, United States
Dai Yeun Jeong
Asia Climate Change Education Center, Korea, Republic of
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Jiri Dedecek
J Heyrovsky Institute of Physical Chemistry , Czech Republic
Vladimir G Chigrinov
Hong Kong University of Science and Technology, Russian Federation
Osman Adiguzel
Firat University, Turkey
Uday Som
Shizuoka University, Japan
Rabeharitsara Andry Tahina
GPCI-ESPA Antananarivo University, MadagascarSubmit your abstract Today
Title : Nanomaterials to fight cancer, cysts, infection, and numerous other health ailments: Human data
Thomas J Webster, Brown University, United States
Title : Application of vanadium, tantalum and chromium single-site zeolite catalysts in catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : Influence of various catalysts on H₂ enhancement and CO2 capture during syngas upgrading
Enrico Paris, CREA-IT & DIAEE, Italy
Title : Plasma deposited nanocomposite thin films as integrated catalytic systems on structured packings: Concepts and applications
Hanna Kierzkowska Pawlak, Lodz University of Technology, Poland
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model via bi-odesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : The Concept and Implications of Low Carbon Green Growth
Dai Yeun Jeong, Asia Climate Change Education Center, Korea, Republic of
Title : Post-translational modifications of proteins in cardiovascular diseases
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Morphological studies of quaternary alloys
Yarub Al Douri, European Academy of Sciences, Belgium
Title : Advances in heterogeneous catalysis for green conversion of propene to aldehydes and alcohols
Ram Sambhar Shukla, CSIR-Central Salt and Marine Chemicals Research Institute (CSMCRI), India
Title : Advanced nanostructures for carbon neutrality and sustainable H₂ energy
Tokeer Ahmad, Jamia Millia Islamia, India